These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 5427678)

  • 1. [Correlations between the histological changes and results of treatment with corticoids and immunosuppressive agents in primary glomerulonephritis].
    Lagrue G; Bariety J
    Minerva Med; 1970 Jul; 61(55):3054-63. PubMed ID: 5427678
    [No Abstract]   [Full Text] [Related]  

  • 2. [Correlation between histological changes and the results of treatment with corticoids and immunosuppressive drugs in primary glomerulopathies].
    Lagrue G; Bariety J
    Rev Clin Esp; 1970 Mar; 116(6):571-80. PubMed ID: 5517882
    [No Abstract]   [Full Text] [Related]  

  • 3. [The pharmacotherapy of chronic glomerulonephritis].
    Ratner MIa; Biriukova LS
    Klin Med (Mosk); 1992 Jan; 70(1):114-9. PubMed ID: 1608196
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunosuppressive therapy in steroid-resistant proliferative glomerulonephritis accompanied by the nephrotic syndrome.
    White RH; Cameron JS; Trounce JR
    Br Med J; 1966 Oct; 2(5518):853-60. PubMed ID: 5917404
    [No Abstract]   [Full Text] [Related]  

  • 5. [Indications and limitations of immunosuppressive therapy in chronic glomerulonephritis].
    Ponticelli C; Brancaccio D; Locatelli F; Imbasciati E
    Minerva Nefrol; 1969; 16(3):228-34. PubMed ID: 5356052
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunosuppressive therapy. 2.
    Skinner MD; Schwartz RS
    N Engl J Med; 1972 Aug; 287(6):281-6. PubMed ID: 4556903
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunosuppressive treatment of glomerulonephritis and nephrotic syndrome].
    Stojimirović B
    Med Glas; 1971; 25(7):273-6. PubMed ID: 5148090
    [No Abstract]   [Full Text] [Related]  

  • 8. Alkylating agents and purine analogues in primary glomerulonephritis with nephrotic syndrome.
    Ponticelli C; Passerini P
    Nephrol Dial Transplant; 1991; 6(6):381-8. PubMed ID: 1876280
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapy of glomerulonephritis with corticosteroids and immunosuppressive agents].
    Kampf D; Baethke R
    Dtsch Med Wochenschr; 1974 May; 99(21):1151-6. PubMed ID: 4602084
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug therapy. Immunosuppressive agents. I.
    Kaplan SR; Calabresi P
    N Engl J Med; 1973 Nov; 289(18):952-5. PubMed ID: 4582749
    [No Abstract]   [Full Text] [Related]  

  • 11. [Indications for immunosuppressive treatment in kidney diseases of children].
    Wojnarowski M; Wyszyńska T
    Pediatr Pol; 1969 May; 44(5):525-30. PubMed ID: 4183009
    [No Abstract]   [Full Text] [Related]  

  • 12. [The treatment of the nephrotic syndrome with the aid of immunosuppressive drugs].
    Zosin C; Mănescu N; Schwarzkopf A
    Med Interna (Bucur); 1967 Sep; 19(9):1067-75. PubMed ID: 6064760
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunosuppressive agents in the treatment of the nephrotic syndrome and glomerulonephritis in children.
    Cameron JS
    Paediatrician; 1979; 8(5-6):364-77. PubMed ID: 392408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of the nephrotic syndrome.
    Linshaw MA; Gruskin AB
    Clin Pediatr (Phila); 1974 Jan; 13(1):45-51. PubMed ID: 4588668
    [No Abstract]   [Full Text] [Related]  

  • 15. [The immuno-depressive agents in nephrology. Trial treatments of chronic primary glomerular diseases].
    Lagrue G; Bariéty J; Halpern B; Milliez P
    Presse Med (1893); 1967 Sep; 75(35):1779-81. PubMed ID: 6054132
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of corticoid-resistant nephrotic syndrome: a still unresolved problem].
    Damiani B; Giani M; Consalvo G; Carcano A; Ghio L; Edefonti A
    Pediatr Med Chir; 1995; 17(1):9-15. PubMed ID: 7739938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of immunosuppressive agents in the treatment of nephrosis in children].
    Cochat P; David L; Parchoux B; Freycon MT; Larbre F
    Pediatrie; 1987; 42(7):519-26. PubMed ID: 3328154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results of immunosuppressive treatment of nephrotic syndrome].
    Przybyl L; Salwa-Kubasik W; Urbański K; Wróz M; Hryniewiecki J
    Pol Tyg Lek; 1973 Jun; 28(26):990-3. PubMed ID: 4727614
    [No Abstract]   [Full Text] [Related]  

  • 19. Cytotoxic drugs in steroid-resistant renal disease. Alkylating and antimetabolic agents in the treatment of nephrotic syndrome, lupus nephritis, chronic glomerulonephritis, and purpura nephritis in children.
    Grupe WE; Heymann W
    Am J Dis Child; 1966 Nov; 112(5):448-58. PubMed ID: 5917978
    [No Abstract]   [Full Text] [Related]  

  • 20. [Primary glomerulopathies--therapy using corticosteroids and cytostatics (immunosuppressive agents)].
    Lagrue G; Bariéty J
    Munch Med Wochenschr; 1970 Mar; 112(12):515-22. PubMed ID: 5467836
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.